Dr Debalina Bose
Senior Manager, The Esthetic Clinics Clinical Research Organization
Dr. Debalina Bose is an accomplished Biotechnologist and Molecular Biologist, currently serving as Manager at The Esthetic Clinics Clinical Research Organization (TECCRO), Mumbai. She holds a Ph.D. in Biotechnology (2021) from the Indian Institute of Technology (IIT) Kharagpur, with expertise spanning protein biochemistry, molecular docking, radiation oncology, and bioactive peptide therapeutics.
At TECCRO, Dr. Bose spearheads scientific communication and regulatory documentation with a specialized focus on clinical trials. She is deeply involved in the authorship of comprehensive clinical study reports and high-impact manuscripts that adhere to ICH-GCP guidelines and international regulatory standards. Her role bridges medical content strategy with translational research, supporting critical trial components such as protocol development, statistical analysis plans, and outcome reporting. Through her contributions, Dr. Bose plays a pivotal role in advancing evidence-based findings, with her work frequently published in peer-reviewed, PubMed-indexed journals.
Her research portfolio includes the molecular characterization of anticancer peptides, mechanistic studies on radiosensitizers, and AI-driven process innovations in biopharmaceutical and food systems. She is the author of over 15 scientific articles and multiple book chapters (Springer, Elsevier, CRC Press), and holds patents in biogel encapsulation and fruit juice concentration.
Dr. Bose also supports TECCRO’s business development and academic outreach, offering scientific insights into proposal development, client interfacing, and cross-functional collaboration. Her work bridges preclinical research, regulatory science, and clinical translation-positioning her as a critical driver of TECCRO’s mission to advance evidence-based innovation in biomedical and aesthetic research.